Valeant Pharmaceuticals International (VRX) 23.78 $VRX
Valeant's CEO Bought VRX Shares, But Here's Why You Shouldn't
Zacks Premium Research - Zacks Investment Research - Mon Jun 13, 1:39PM CDT
Joseph Papa, CEO of Valeant Pharmaceuticals, has bought close to $5 million of his company's shares. Is he bluffing though? Earnings are ultimately the key to investing, and here's how VRX's earnings expectations have been trending
VRX: 23.78 (-0.36)
Why Andrew Left and Citron Are Wrong About Facebook (FB) Stock
Ryan McQueeney - Zacks Investment Research - Mon Jun 13, 1:15PM CDT
Shares of Facebook (FB) are down about 2.5% Monday following the news that notorious short-seller Andrew Left, founder of Citron Research, was shorting shares of the social media giant. Here's why their wrong.
GPRO: 9.97 (-0.29), VRX: 23.78 (-0.36), LNKD: 192.21 (+61.13), FB: 113.95 (-2.67), MSFT: 50.14 (-1.34)
Valeant To Participate In FDA Advisory Committee Meeting On July 19
PR Newswire - Thu Jun 09, 4:40PM CDT
Committee to Review Valeant's BLA 761032 Brodalumab Subcutaneous Injection For Treatment of Adult Patients with Moderate to Severe Plaque Psoriasis
VRX: 23.78 (-0.36), AZN: 27.60 (-0.37), VRX.TO: 30.52 (-0.28)
Learn how to target a 20% return on Valeant Pharmaceuticals, or get option-trade ideas on Lululemon, First Solar, UnitedHealth, and National Oilwell Varco or any stock you choose
PR Newswire - Thu Jun 09, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for VRX, LULU, FSLR, UNH and NOV.
NOV: 34.59 (-0.44), VRX: 23.78 (-0.36), FSLR: 47.79 (-0.72), UNH: 138.09 (-1.15), LULU: 70.21 (-0.33)
Valeant (VRX) Stock Down on Bleak View, Q1 Earnings Miss
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 10:24AM CDT
Shares of Valeant Pharmaceuticals International, Inc. (VRX) were down 14.6% after the company slashed its guidance for 2016 due to continued weakness across most of its business franchises.
ABT: 37.86 (-0.54), JNJ: 116.79 (-0.22), VRX: 23.78 (-0.36), ARQL: 1.73 (-0.05)
Company News for June 08, 2016
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 9:10AM CDT
Companies in the News are: HTZ,ALXN,VRX,UNFI
VRX: 23.78 (-0.36), UNFI: 42.85 (+0.50), HTZ: 10.50 (-0.18), ALXN: 133.32 (-2.29)
Post-Earnings Coverage Valeant Pharma under the Microscope
ACCESSWIRE - Wed Jun 08, 8:15AM CDT
Valeant Pharmaceuticals Slumps after cutting its Forecast
PRGO: 99.06 (+0.55), VRX: 23.78 (-0.36), GILD: 83.98 (-0.47)
Apollo Global (APO) Submits Bid to Acquire Concordia
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:03AM CDT
Apollo Global Management, LLC (APO) has reportedly submitted a bid in the final round of Concordia Healthcare Corp. (CXRX) auction process.
VRX: 23.78 (-0.36), APO: 15.81 (-0.29), BX: 25.74 (-0.33), CXRX: 23.11 (-0.69)
Chevron and Zillow advance while Ralph Lauren skids
AP - Tue Jun 07, 4:38PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Tuesday:
VRX: 23.78 (-0.36), UNFI: 42.85 (+0.50), ALXN: 133.32 (-2.29), ZG: 32.62 (+0.16), CVX: 102.10 (+0.12), VZ: 52.57 (-0.10), RL: 93.83 (-1.97), VRX.TO: 30.52 (-0.28), Z: 32.40 (+0.18)
How to Tell if You're in a Cult Stock
David Bartosiak - Zacks Investment Research - Tue Jun 07, 4:36PM CDT
Some companies have investors that are more like cult members than share owners.
SBUX: 55.04 (+0.17), HLF: 60.62 (-1.27), TSLA: 217.87 (-0.92), VRX: 23.78 (-0.36), JPM: 63.27 (-0.57)
Valeant Pharmaceuticals To Webcast 2016 Annual Meeting Of Shareholders
PR Newswire - Tue Jun 07, 4:00PM CDT
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will conduct a live webcast of the company's annual meeting of shareholders for the year ended December 31, 2015. The meeting and webcast will be held on Tuesday, June 14, 2016 at 9:00 a.m. ET at the International Headquarters, Laval Office: 2150 Saint Elzear Blvd. West, Laval Quebec, Canada H7L 4A8. Only shareholders of record at the close of business on the record date of April 20, 2016 will be entitled to vote at the meeting and any adjournments or postponements thereof.
VRX: 23.78 (-0.36), VRX.TO: 30.52 (-0.28)
Valeant Pharmaceuticals International Falls 13.67% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Jun 07, 11:44AM CDT
Valeant Pharmaceuticals International (NYSE:VRX) traded in a range yesterday that spanned from a low of $22.52 to a high of $25.72. Yesterday, the shares fell 13.7%, which took the trading range below the 3-day low of $28.53 on volume of 80.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VRX: 23.78 (-0.36)
Here's Why Valeant Pharmaceuticals (VRX) is Crashing Today
Madeleine Johnson - Zacks Investment Research - Tue Jun 07, 10:56AM CDT
On Tuesday, shares of struggling pharmaceutical company Valent Pharmaceuticals Inc. (VRX) are crashing, down almost 15% in morning trading after the company reported dismal first quarter results.
VRX: 23.78 (-0.36)
Valeant Pharmaceuticals Reports First Quarter 2016 Financial Results
PR Newswire - Tue Jun 07, 5:00AM CDT
-- Total Revenues of $2.4 billion, an increase of 9% versus the first quarter of 2015 (restated)
VRX: 23.78 (-0.36), VRX.TO: 30.52 (-0.28)
5 Stocks to Watch this Week 6/6 - PAY, VRX, LULU, RH, HRB
ESTMZ - Mon Jun 06, 7:24PM CDT
Tuesday, June 7 Wednesday, June 8 Thursday, June 9 VeriFone Systems ( PAY ) Information Technology - IT Services | Reports June 7, after the close. The Estimize consensus is calling for earnings of 54 cents per share on...
RH: 25.68 (-0.88), VRX: 23.78 (-0.36), SPY: 208.45 (-1.62), PAY: 19.14 (-0.52), LULU: 70.21 (-0.33), HRB: 23.75 (-0.48)
Is it Time to Buy Valeant Pharmaceuticals?
ESTMZ - Mon Jun 06, 3:01PM CDT
Valeant Pharmaceuticals ( VRX ) Health Care - Pharmaceuticals | Reports June 7, Before Market Opens Key Takeaways The Estimize consensus is calling for earnings per share of $1.46 on $2.36 billion in revenue, 4 cents higher than Wall Street on...
VRX: 23.78 (-0.36), SPY: 208.45 (-1.62)
Business Highlights
By The Associated Press - AP - Fri Jun 03, 5:00PM CDT
___
VRX: 23.78 (-0.36), GOOGL: 731.88 (-1.31), GOOG: 718.36 (-1.05), VRX.TO: 30.52 (-0.28)
Valeant's CEO Bought VRX Shares, But Here's Why You Shouldn't
Zacks Premium Research - Zacks Investment Research - Mon Jun 13, 1:39PM CDT
Joseph Papa, CEO of Valeant Pharmaceuticals, has bought close to $5 million of his company's shares. Is he bluffing though? Earnings are ultimately the key to investing, and here's how VRX's earnings expectations have been trending
VRX: 23.78 (-0.36)
Why Andrew Left and Citron Are Wrong About Facebook (FB) Stock
Ryan McQueeney - Zacks Investment Research - Mon Jun 13, 1:15PM CDT
Shares of Facebook (FB) are down about 2.5% Monday following the news that notorious short-seller Andrew Left, founder of Citron Research, was shorting shares of the social media giant. Here's why their wrong.
GPRO: 9.97 (-0.29), VRX: 23.78 (-0.36), LNKD: 192.21 (+61.13), FB: 113.95 (-2.67), MSFT: 50.14 (-1.34)
Valeant To Participate In FDA Advisory Committee Meeting On July 19
PR Newswire - Thu Jun 09, 4:40PM CDT
Committee to Review Valeant's BLA 761032 Brodalumab Subcutaneous Injection For Treatment of Adult Patients with Moderate to Severe Plaque Psoriasis
VRX: 23.78 (-0.36), AZN: 27.60 (-0.37), VRX.TO: 30.52 (-0.28)
Learn how to target a 20% return on Valeant Pharmaceuticals, or get option-trade ideas on Lululemon, First Solar, UnitedHealth, and National Oilwell Varco or any stock you choose
PR Newswire - Thu Jun 09, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for VRX, LULU, FSLR, UNH and NOV.
NOV: 34.59 (-0.44), VRX: 23.78 (-0.36), FSLR: 47.79 (-0.72), UNH: 138.09 (-1.15), LULU: 70.21 (-0.33)
Valeant (VRX) Stock Down on Bleak View, Q1 Earnings Miss
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 10:24AM CDT
Shares of Valeant Pharmaceuticals International, Inc. (VRX) were down 14.6% after the company slashed its guidance for 2016 due to continued weakness across most of its business franchises.
ABT: 37.86 (-0.54), JNJ: 116.79 (-0.22), VRX: 23.78 (-0.36), ARQL: 1.73 (-0.05)
Company News for June 08, 2016
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 9:10AM CDT
Companies in the News are: HTZ,ALXN,VRX,UNFI
VRX: 23.78 (-0.36), UNFI: 42.85 (+0.50), HTZ: 10.50 (-0.18), ALXN: 133.32 (-2.29)
Post-Earnings Coverage Valeant Pharma under the Microscope
ACCESSWIRE - Wed Jun 08, 8:15AM CDT
Valeant Pharmaceuticals Slumps after cutting its Forecast
PRGO: 99.06 (+0.55), VRX: 23.78 (-0.36), GILD: 83.98 (-0.47)
Apollo Global (APO) Submits Bid to Acquire Concordia
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:03AM CDT
Apollo Global Management, LLC (APO) has reportedly submitted a bid in the final round of Concordia Healthcare Corp. (CXRX) auction process.
VRX: 23.78 (-0.36), APO: 15.81 (-0.29), BX: 25.74 (-0.33), CXRX: 23.11 (-0.69)
Chevron and Zillow advance while Ralph Lauren skids
AP - Tue Jun 07, 4:38PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Tuesday:
VRX: 23.78 (-0.36), UNFI: 42.85 (+0.50), ALXN: 133.32 (-2.29), ZG: 32.62 (+0.16), CVX: 102.10 (+0.12), VZ: 52.57 (-0.10), RL: 93.83 (-1.97), VRX.TO: 30.52 (-0.28), Z: 32.40 (+0.18)
How to Tell if You're in a Cult Stock
David Bartosiak - Zacks Investment Research - Tue Jun 07, 4:36PM CDT
Some companies have investors that are more like cult members than share owners.
SBUX: 55.04 (+0.17), HLF: 60.62 (-1.27), TSLA: 217.87 (-0.92), VRX: 23.78 (-0.36), JPM: 63.27 (-0.57)
Valeant Pharmaceuticals To Webcast 2016 Annual Meeting Of Shareholders
PR Newswire - Tue Jun 07, 4:00PM CDT
Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will conduct a live webcast of the company's annual meeting of shareholders for the year ended December 31, 2015. The meeting and webcast will be held on Tuesday, June 14, 2016 at 9:00 a.m. ET at the International Headquarters, Laval Office: 2150 Saint Elzear Blvd. West, Laval Quebec, Canada H7L 4A8. Only shareholders of record at the close of business on the record date of April 20, 2016 will be entitled to vote at the meeting and any adjournments or postponements thereof.
VRX: 23.78 (-0.36), VRX.TO: 30.52 (-0.28)
Valeant Pharmaceuticals International Falls 13.67% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Jun 07, 11:44AM CDT
Valeant Pharmaceuticals International (NYSE:VRX) traded in a range yesterday that spanned from a low of $22.52 to a high of $25.72. Yesterday, the shares fell 13.7%, which took the trading range below the 3-day low of $28.53 on volume of 80.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
VRX: 23.78 (-0.36)
Here's Why Valeant Pharmaceuticals (VRX) is Crashing Today
Madeleine Johnson - Zacks Investment Research - Tue Jun 07, 10:56AM CDT
On Tuesday, shares of struggling pharmaceutical company Valent Pharmaceuticals Inc. (VRX) are crashing, down almost 15% in morning trading after the company reported dismal first quarter results.
VRX: 23.78 (-0.36)
Valeant Pharmaceuticals Reports First Quarter 2016 Financial Results
PR Newswire - Tue Jun 07, 5:00AM CDT
-- Total Revenues of $2.4 billion, an increase of 9% versus the first quarter of 2015 (restated)
VRX: 23.78 (-0.36), VRX.TO: 30.52 (-0.28)
5 Stocks to Watch this Week 6/6 - PAY, VRX, LULU, RH, HRB
ESTMZ - Mon Jun 06, 7:24PM CDT
Tuesday, June 7 Wednesday, June 8 Thursday, June 9 VeriFone Systems ( PAY ) Information Technology - IT Services | Reports June 7, after the close. The Estimize consensus is calling for earnings of 54 cents per share on...
RH: 25.68 (-0.88), VRX: 23.78 (-0.36), SPY: 208.45 (-1.62), PAY: 19.14 (-0.52), LULU: 70.21 (-0.33), HRB: 23.75 (-0.48)
Is it Time to Buy Valeant Pharmaceuticals?
ESTMZ - Mon Jun 06, 3:01PM CDT
Valeant Pharmaceuticals ( VRX ) Health Care - Pharmaceuticals | Reports June 7, Before Market Opens Key Takeaways The Estimize consensus is calling for earnings per share of $1.46 on $2.36 billion in revenue, 4 cents higher than Wall Street on...
VRX: 23.78 (-0.36), SPY: 208.45 (-1.62)
Business Highlights
By The Associated Press - AP - Fri Jun 03, 5:00PM CDT
___
VRX: 23.78 (-0.36), GOOGL: 731.88 (-1.31), GOOG: 718.36 (-1.05), VRX.TO: 30.52 (-0.28)
